POSB161 Cost-Effectiveness of Dapagliflozin Plus Standard Treatment Compared to Standard Treatment for the Management of Heart Failure with Reduced Ejection Fraction in Colombia.

Saved in:
Bibliographic Details
Title: POSB161 Cost-Effectiveness of Dapagliflozin Plus Standard Treatment Compared to Standard Treatment for the Management of Heart Failure with Reduced Ejection Fraction in Colombia.
Authors: Gil Rojas, Y1 (AUTHOR), Lasalvia, P2 (AUTHOR), Garcia Peña, AA3 (AUTHOR)
Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS92-S92. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2021.11.434